Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
- USD | -.--% | -.--% | -.--% |
05-01 | Stifel Initiates Cullinan Oncology With Buy Rating, $40 Price Target | MT |
04-29 | Cullinan Therapeutics Appoints Mary Kay Fenton as CFO | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration1st Jan change | Capi. | |
---|---|---|
-.--% | 4M | |
-1.27% | 4.45B | |
-13.09% | 3.46B | |
+4.94% | 1.62B | |
+30.96% | 1.23B | |
+26.12% | 922M | |
+82.85% | 881M | |
+15.81% | 585M | |
-24.87% | 570M | |
-.--% | 155M |
- Stock Market
- Equities
- CGEM Stock
- News Consolidated Gems, Inc.
- Cullinan Oncology Says US FDA Approves Investigational New Drug Application for CLN-978